The global antibody therapeutics market is undergoing a period of remarkable growth. This expansion can be attributed to several factors, like the increasing prevalence of chronic diseases, advancements in biotechnology, and growing utilization of biologics. The market is projected to grow at a compounding annual growth rate of Y% during the foreca